These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7834936)

  • 41. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nifedipine in the treatment of moderate and severe arterial hypertension. Long-term effect on arterial pressure and on the left ventricle].
    López NC; Corral JL; Perozo M; García P; Bustillo N; Arreaza MR; Arocha I
    Rev Esp Cardiol; 1997 Aug; 50(8):567-72. PubMed ID: 9340698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy.
    Müller-Brunotte R; Kahan T; Malmqvist K; Edner M;
    J Hum Hypertens; 2003 Dec; 17(12):841-9. PubMed ID: 14704728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors.
    Franz IW; Tönnesmann U; Müller JF
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):631-9. PubMed ID: 9657621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study.
    Galderisi M; Lomoriello VS; Santoro A; Esposito R; Olibet M; Raia R; Di Minno MN; Guerra G; Mele D; Lombardi G
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1190-8. PubMed ID: 20810245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nifedipine on carotid and femoral arterial wall thickness in previously untreated hypertensive patients.
    Terpstra WF; May JF; Smit AJ; de Graeff PA; Crijns HJ
    Blood Press Suppl; 2003 May; 1():22-9. PubMed ID: 12800984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F; Seguro C; Pargentino E
    Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of nicardipine on left ventricular hemodynamic patterns in systemic hypertension.
    de Simone G; Costantino G; Soro S; Di Lorenzo L; Moccia D; Buonissimo S; Ferrara LA
    Am J Hypertens; 1989 Mar; 2(3 Pt 1):139-45. PubMed ID: 2522007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular mass regression with amlodipine in elderly hypertensives.
    Singh NK; Gupta SK; Agrawal BV
    Clin Exp Hypertens; 1999; 21(1-2):113-9. PubMed ID: 10052647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Once-daily nifedipine sustained release (nifelan) on forearm vascular resistance and regression of left ventricular hypertrophy in patients with mild to moderate essential hypertension.
    Chang KC; Cherng WJ
    Changgeng Yi Xue Za Zhi; 1998 Mar; 21(1):28-36. PubMed ID: 9607261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
    Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
    Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study.
    Peteiro J; Alvarez N; Calviño R; Penas M; Ribera F; Castro Beiras A
    Cardiology; 1994; 85(5):273-83. PubMed ID: 7850816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
    Mancusi C; Gerdts E; De Simone G; Abdelhai YM; Lønnebakken MT; Boman K; Wachtell K; Dahlöf B; Devereux RB
    Blood Press; 2014 Aug; 23(4):206-12. PubMed ID: 24564262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.